ClinicalTrials.Veeva

Menu

Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis (SAPRIS-SERO)

I

Institut National de la Santé Et de la Recherche Médicale, France

Status

Completed

Conditions

SARS-CoV 2

Treatments

Biological: Non applicable

Study type

Observational

Funder types

Other

Identifiers

NCT04392388
C20-26
2020-A01195-34 (Other Identifier)

Details and patient eligibility

About

This study aims to quantify and follow the cumulative incidence of SARS-CoV-2 infection in the French population using serological tests and to assess the determinants of infection from Constances, E3N-E4N, ELFE-Epipage 2 and NutriNet-Santé cohorts.

Full description

The primary objective is to assess the cumulative incidence of infection in the general population using dried blood spot sampling.

The secondary objectives are:

  • To identify factors associated with a positive SARS-CoV-2 infection (positive serology) and to characterize the durability of the serological response to SARS-CoV-2
  • To identify associations of symptoms predictive of a SARS-CoV-2 infection
  • To estimate the health care use associated with a SARS-CoV-2 infection
  • To estimate the fraction of sub-clinical infections or infections not captured by the healthcare system;
  • To study the acceptability of a mass anti-SARS-CoV-2 serological testing and the impact of its result, linked with social inequalities in health;
  • To estimate the individual and collective impact of containment and other preventive measures on the risk of SARS-CoV-2 infection;
  • To study the impact of social and territorial inequalities on seroprevalence levels.

Enrollment

96,883 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • non applicable, already enrolled in the cohorts

Exclusion criteria

  • non applicable

Trial design

96,883 participants in 1 patient group

SAPRIS-SERO
Description:
SAPRIS-SERO enrolls participants from cohorts entitled: Constances, E3N-E4N, ELFE, Epipage 2 and NutriNet-Santé.
Treatment:
Biological: Non applicable

Trial contacts and locations

1

Loading...

Central trial contact

Fabrice Carrat

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems